NVIDIA announced its agentic AI platform for healthcare and life sciences at GTC 2026, with CEO Jensen Huang positioning autonomous AI systems as the next major industry inflection point. The platform enables AI systems to act independently to achieve specific goals without constant human oversight.
The healthcare announcements include partnerships with Roche to develop AI factories for drug discovery and development processes. NVIDIA also introduced a protein design reasoning model that can autonomously design and optimize protein structures for therapeutic applications.